Tingting Chen

Tingting Chen

Auto-generated profile, based on publicly available information

Tingting Chen

School of Traditional Chinese Medicine, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang District, Shenyang, Liaoning 110016, PR China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
TCTingting Chen
Tingting Chen
XLXiaoyu Li
Xiaoyu Li
QLQiuting Li
Qiuting Li
LHLihong Huang
Lihong Huang
QCQingqing Cai
Qingqing Cai
JWJina Wang
Jina Wang
The mortality rate from COVID-19 appears to be higher in solid organ transplant (SOT) recipients when compared with other populations. Vaccination is a key strategy to prevent the COVID-19 pandemic. However, it is unclear how readily SOT recipients will get vaccinated against COVID-19. We conducted an internet-based survey to investigate the vaccination willingness among Chinese SOT recipients and further explore possible influencing factors. Eight hundred and thirteen respondents participated in the survey. Overall, 46 (5.7%) recipients were vaccinated against COVID-19, while 767 (94.3%) were not. Among those not vaccinated, 175 (22.8%) intended to be vaccinated, while 592 (77.2%) were categorized as vaccine-hesitant. The most common reason for vaccination hesitancy is fear of preexisting comorbidities, followed by fear of side effects and doctors’ negative advice. Factors associated with vaccination willingness were as follows: with liver transplantation, the main source of information on COVID-19 vaccines was from medical doctors, scientists, and scientific journals, with at least college-level education, positive intention toward influenza vaccination during the current season, perceived importance of vaccination for SOT recipients, and having been vaccinated against influenza during the last season. Our survey indicated the necessity for SOT recipients to receive more comprehensive and accessible health education about vaccination and emphasized the critical role of transplantation physicians in promoting vaccine acceptance among SOT recipients. We hope that our survey results will help governments to better target communication in the ongoing COVID-19 vaccination campaign.

1 June 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XXXiajing Xu
Xiajing Xu
SYShuang Yan
Shuang Yan
YZYu Zhang
Yu Zhang
LCLiqi Cao
Liqi Cao
TCTingting Chen
Tingting Chen
YPYing-Ni Pan
Ying-Ni Pan

1 January 2019 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
CTChen Tingting
Chen Tingting
WYWang Yuzhu
Wang Yuzhu
ZLZhang Lin
Zhang Lin
LRLi Ran
Li Ran
LJLi Jing
Li Jing
QLQianZhou Lv
QianZhou Lv
Both vitamin K antagonists (VKAs) and novel oral anticoagulants (NOACs) are effective for stroke prevention in nonvalvular atrial fibrillation (NVAF) patients. This study evaluated the utilization of VKA and NOACs in NVAF patients before and after catheter ablation in China. Prescription data were retrospectively collected between January 1, 2016, and December 31, 2016, including indication of use, dose, renal function, and risk assessment (CHA2DS2-VASc score and HAS-BLED score) in Zhongshan Hospital of Fudan University. Trends and factors associated with anticoagulants use before and after ablation were evaluated. A total of 475 patients with NVAF who received ablation were included in the analysis. Of all, 53.26% of them received antithrombotic therapy preablation. Warfarin was prescribed in 35.26%, with NOACs in 11.37%. Four hundred seventy-three patients received antithrombotic therapy (99.58%) postablation, 236 patients with NOACs (49.68%). CHA2DS2-VASc score, HAS-BLED score, hypertension, diabetes mellitus, and alcohol were independently associated with anticoagulant utilization before catheter ablation. The higher CHA2DS2-VASc score was associated with less frequent prescription of NOACs postablation. The preablation anticoagulation use was still inadequate in China, and CHA2DS2-VASc score was a significant factor influencing the preablation anticoagulant utilization. The utilization rate of NOACs increased significantly postablation, especially for dabigatran, which implied that more physicians prefer to prescribe NOACs for NVAF patients after ablation in our country and may be attributed to the aspects such as ease of NOAC use but also possibly the greater safety and efficacy. Furthermore, the physicians may reluctant to use NOACs for high stroke risk atrial fibrillation patients after catheter ablation.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
AGAngelica Maria Sabogal Guaqueta
Angelica Maria Sabogal Guaqueta
AMAlejandro Marmolejo
Alejandro Marmolejo
MTMarina Trombetta-Lima
Marina Trombetta-Lima
AOAsmaa Oun
Asmaa Oun
TCTingting Chen
Tingting Chen
ADAmalia Dolga
Amalia Dolga